ERBB2 and breast cancer: Several HER2-targeted vehicles, such as monoclonal antibodies (mAb), antibody-based fragments (Fab), diabodies, minibodies, nanobodies (Nb) and affibodies, have been explored for HER2+ BC imaging and TRNT in the past few years [16].